CLOV
Overvalued by 213.6% based on the discounted cash flow analysis.
Market cap | $1.47 Billion |
---|---|
Enterprise Value | $1.31 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $-0.08 |
Beta | 1.93 |
Outstanding Shares | 497,056,331 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -57.1 |
---|---|
PEG | 61.17 |
Price to Sales | 1.49 |
Price to Book Ratio | - |
Enterprise Value to Revenue | 0.89 |
Enterprise Value to EBIT | -40.49 |
Enterprise Value to Net Income | -53 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data
Clover Health is a healthcare technology company with a deeply rooted mission of improving every life. Clover uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outco...